Adaptive Biotechnologies
Price & Volume
Stats
See more52W Range | $12-$30.74 |
Market Cap | $4.2B |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $308M |
Revenue Growth (YoY) | 21.5% |
Gross Profit (12 Mos) | $144.6M |
Diluted EPS | -$0.41 |
News
See moreYahoo Finance • 18 days ago
Adaptive Biotechnologies (ADPT) Jumped, So What Is Driving Attention Now?
Yahoo Finance • 19 days ago
NCCN’s Myeloma MRD Update Spotlighting clonoSEQ Could Be A Game Changer For Adaptive Biotechnologies (ADPT)
Yahoo Finance • 26 days ago
10 mid-cap healthcare stocks with the strongest momentum grades
Yahoo Finance • 3 months ago
Cathie Wood reshuffles portfolio ahead of Q2, buys SpaceX, Eli Lilly, Meta; pares AMD, Roku
About
CEO | Mr. Chad M. Robins M.B.A. |
CFO | Mr. Kyle Piskel |
Address | 1165 Eastlake Avenue East, Seattle, WA, United States, 98109 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Full-Time Employees | 624 |